Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Q3 2025 value amounting to 0.29%.

  • Catalyst Pharmaceuticals' Return on Capital Employed rose 200.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.36% for FY2024, which is 1100.0% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.29% for Q3 2025, which was up 200.0% from 0.29% recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Return on Capital Employed ranged from a high of 0.37% in Q2 2023 and a low of 0.15% during Q2 2024
  • In the last 5 years, Catalyst Pharmaceuticals' Return on Capital Employed had a median value of 0.27% in 2024 and averaged 0.27%.
  • As far as peak fluctuations go, Catalyst Pharmaceuticals' Return on Capital Employed plummeted by -2200bps in 2021, and later surged by 1500bps in 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then surged by 33bps to 0.34% in 2022, then tumbled by -31bps to 0.24% in 2023, then increased by 19bps to 0.28% in 2024, then rose by 4bps to 0.29% in 2025.
  • Its last three reported values are 0.29% in Q3 2025, 0.29% for Q2 2025, and 0.3% during Q1 2025.